Clinical efficacy evaluation of a traditional Miao technique of crossbow needle therapy in the treatment of knee osteoarthritis: a multi-center randomized controlled trial.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
22 Jun 2020
Historique:
received: 07 05 2019
accepted: 12 06 2020
entrez: 24 6 2020
pubmed: 24 6 2020
medline: 18 3 2021
Statut: epublish

Résumé

Knee osteoarthritis (KOA) seriously reduces quality of life and is a major threat to the health of the middle-aged and elderly. This study aimed to assess the efficacy of Miao crossbow needle therapy vs. acupuncture for KOA therapy. This multicenter, randomized controlled trial was performed at three hospitals between April 2016 and December 2016. The patients were randomized to receive crossbow needle (CN) or acupuncture (AT). All treatments were completed within 46 days. Evaluation of treatment was conducted on the 46th, 62nd, and 77th days. The primary endpoint was change of Western Ontario and McMaster Osteoarthritis Index (WOMAC) score on the 46th day. The secondary endpoints included WOMAC score, the Lysholm knee score, the Japanese Orthopedic Association (JOA) knee score, visual analog scale (VAS), and the MOS 36-item short-form health survey (SF-36), on the 46th, 62nd, and 77th day. Finally, data of 301 participants were analyzed for the efficacy of treatment. Compared with AT, there was a larger change of WOMAC score in the CN group after treatment [- 25.0 (95% CI - 27.0, - 23.0) vs. - 18.8 (95% CI - 20.8, - 16.9), P < 0.001]. In the CN group, the WOMAC score was lower at all three time points (P = 0.008, P = 0.003, P < 0.001 respectively), while the Lysholm knee score (P = 0.03) and JOA score (P = 0.013) were higher and the VAS score (P = 0.011) was lower on the 77th day. Both Miao crossbow needle therapy and acupuncture reduced the WOMAC score. Miao crossbow needle therapy can be an alternative method for treating patients with knee osteoarthritis. ChiCTR, ChiCTR-INR-16008032. Registered on 12 March 2016.

Sections du résumé

BACKGROUND BACKGROUND
Knee osteoarthritis (KOA) seriously reduces quality of life and is a major threat to the health of the middle-aged and elderly. This study aimed to assess the efficacy of Miao crossbow needle therapy vs. acupuncture for KOA therapy.
METHODS METHODS
This multicenter, randomized controlled trial was performed at three hospitals between April 2016 and December 2016. The patients were randomized to receive crossbow needle (CN) or acupuncture (AT). All treatments were completed within 46 days. Evaluation of treatment was conducted on the 46th, 62nd, and 77th days. The primary endpoint was change of Western Ontario and McMaster Osteoarthritis Index (WOMAC) score on the 46th day. The secondary endpoints included WOMAC score, the Lysholm knee score, the Japanese Orthopedic Association (JOA) knee score, visual analog scale (VAS), and the MOS 36-item short-form health survey (SF-36), on the 46th, 62nd, and 77th day.
RESULTS RESULTS
Finally, data of 301 participants were analyzed for the efficacy of treatment. Compared with AT, there was a larger change of WOMAC score in the CN group after treatment [- 25.0 (95% CI - 27.0, - 23.0) vs. - 18.8 (95% CI - 20.8, - 16.9), P < 0.001]. In the CN group, the WOMAC score was lower at all three time points (P = 0.008, P = 0.003, P < 0.001 respectively), while the Lysholm knee score (P = 0.03) and JOA score (P = 0.013) were higher and the VAS score (P = 0.011) was lower on the 77th day.
CONCLUSION CONCLUSIONS
Both Miao crossbow needle therapy and acupuncture reduced the WOMAC score. Miao crossbow needle therapy can be an alternative method for treating patients with knee osteoarthritis.
TRIAL REGISTRATION BACKGROUND
ChiCTR, ChiCTR-INR-16008032. Registered on 12 March 2016.

Identifiants

pubmed: 32571395
doi: 10.1186/s13063-020-04508-7
pii: 10.1186/s13063-020-04508-7
pmc: PMC7310011
doi:

Types de publication

Equivalence Trial Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

560

Subventions

Organisme : Special Research Project of Traditional Chinese Medicine
ID : 201507006-01

Références

Ann Intern Med. 2004 Dec 21;141(12):901-10
pubmed: 15611487
Arthritis Care Res (Hoboken). 2016 Dec;68(12):1743-1750
pubmed: 27014966
Lancet. 2005 Jul 9-15;366(9480):136-43
pubmed: 16005336
Zhongguo Zhen Jiu. 2011 Aug;31(8):733-7
pubmed: 21894703
Scand J Rheumatol. 1999;28(4):210-5
pubmed: 10503556
Zhongguo Zhen Jiu. 2009 Jan;29(1):53-5
pubmed: 19186724
Arthritis Rheum. 1995 Nov;38(11):1541-6
pubmed: 7488273
Biomed Microdevices. 2009 Dec;11(6):1195-203
pubmed: 19609679
Trials. 2018 Jun 27;19(1):338
pubmed: 29945672
Arch Pharm Res. 2010 Mar;33(3):339-51
pubmed: 20361297
Zhongguo Zhen Jiu. 2011 Mar;31(3):271-5
pubmed: 21644322
Ann Intern Med. 2011 Feb 15;154(4):217-26
pubmed: 21320937

Auteurs

Jing Fu (J)

Guizhou University of Traditional Chinese Medicine, Guiyang, 550000, China.

Hong-Cai Shang (HC)

Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, 100700, China.

Li-Ying Wang (LY)

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China.

Chen Zhao (C)

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China.

Xiao-Fang Yang (XF)

No.2 Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, 550000, China.

Wei-Wei Guo (WW)

Chinese Medicine Hospital of Qiandongnan Miao and Dong Autonomous Prefecture, Kaili, 556000, China.

Chun-Xia Lu (CX)

No.1 Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, 550000, China.

Jin Cui (J)

Guizhou University of Traditional Chinese Medicine, Guiyang, 550000, China. 516260179@qq.com.

Yan-Ping Wang (YP)

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China. wangyanping4816@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH